What's in Fundação Bahiana de Infectologia's pipeline?

Fundação Bahiana de Infectologia has 2 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 1 in Phase 2, 0 in Phase 1.

Which companies overlap with Fundação Bahiana de Infectologia's portfolio?

Top competitors by shared drug class: Charlotte-Paige Rolle, MD, Denver Infectious Disease Consultants, PLLC, Fundacion SEIMC-GESIDA, Hospitales Universitarios Virgen del Rocío, Saint Michael's Medical Center.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/funda-o-bahiana-de-infectologia.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

Fundação Bahiana de Infectologia — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Fundação Bahiana de Infectologia pipeline: 0 marketed, 0 filed, 1 Phase 3, 1 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 1 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Dolutegravir plus lamivudine in a FDC	Dolutegravir plus lamivudine in a FDC	phase 3	Antiretroviral combination (INSTI + NRTI)	HIV integrase; HIV reverse transcriptase	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Charlotte-Paige Rolle, MD · 1 shared drug class
Denver Infectious Disease Consultants, PLLC · 1 shared drug class
Fundacion SEIMC-GESIDA · 1 shared drug class
Hospitales Universitarios Virgen del Rocío · 1 shared drug class
Saint Michael's Medical Center · 1 shared drug class
The University of Texas Health Science Center, Houston · 1 shared drug class
ViiV Healthcare · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Fundação Bahiana de Infectologia:

Cite this brief

Drug Landscape (2026). Fundação Bahiana de Infectologia — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/funda-o-bahiana-de-infectologia. Accessed 2026-05-17.